Search

everythinglearnresearchcommunity

for

Search:↓

The research suggests that SFRP2 and PTGDS proteins might be indicators of female pattern hair loss and could contribute to hair loss.

Zolpidem shows up in hair from the top back of the head after one dose and fades over time, suggesting it gets into hair through blood and sweat.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Trichoscopy is effective for diagnosing different types of non-scarring hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Isotretinoin may effectively treat hereditary hypotrichosis simplex, a rare hair loss condition.

PGD2 stops hair growth and is higher in bald men with AGA.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

N793 may improve hair density in people with mild hair thinning.

Adipose stem cell-derived exosomes may improve hair count and scalp health, potentially outperforming current treatments like minoxidil.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Keratins in Malayan pangolins vary by region, suggesting scales evolved from the tail towards the head.

SesZen-Bio™ improves hair density, thickness, and overall hair health.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Understanding hair follicle anatomy helps diagnose hair disorders.

Apoptosis contributes to hair loss in androgenetic alopecia.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Androgens can both increase body hair and cause scalp hair loss.

The document concludes that hair biology is complex and there are still unanswered questions about hair loss and follicle changes.

Hair transplantation can effectively restore a natural-looking hairline when properly planned and executed.

Prostaglandins may protect hair follicles during chemotherapy.

Hair grows in three stages: growing, transitioning, and resting.

Minoxidil can increase hair density, speed up regrowth in transplanted hair, and slow down further hair loss, especially beneficial for women, young men with thinning hair, and those wanting to reconstruct the back of the scalp.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

No treatment fully prevents hair loss from chemotherapy yet.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.